About US
Contact us
-
Biogen's Daclizumab receives positive opinion to treat multiple sclerosisUS biotechnology company Biogen has announced new data that reveals daclizumab's positive cognitive outcomes, targeted and reversible mechanism of action (MOA), and safety profile in patients sufferin2016/5/4
-
UK's CRT Pioneer Fund invests in research to develop HSF1 drugs for cancerUK's Cancer Research Technology (CRT) Pioneer Fund has invested in research to develop new drugs known as heat-shock factor 1 (HSF1) pathway inhibitors, which would be able to block a protective mecha2016/5/4
-
UK's PolyPhotonix launches sleep mask to treat diabetic retinopathyUK health technology company PolyPhotonix has unveiled its latest treatment for diabetic retinopathy that causes blindness among working-age adults. The new Noctura400 sleep mask launched in the coun2016/5/3
-
EMA recommends Zavicefta to treat multi-drug resistant bacteria in EUThe European Medicines Agency (EMA) has proposed that a marketing authorisation can be granted for Zavicefta (ceftazidime / avibactam) in the European Union (EU). New treatment option Zavicefta is a2016/5/3
-
Johnson & Johnson to acquire dermocosmetics company NeoStrataNew Jersey-based Johnson & Johnson Consumer has entered into a definitive agreement to purchase US dermocosmetics company, NeoStrata. The acquisition will include NeoStrata's affiliates and its p2016/4/29
-
Zymeworks partners with GSK to develop bi-specific antibodiesPrivately-held biotherapeutics company Zymeworks has entered into a licensing agreement with GlaxoSmithKline Pharmaceuticals (GSK) to research, develop and market bi-specific antibodies. Bi-specific2016/4/29
-
EC grants marketing authorisation for Gilead Sciences’ Descovy F/TAFThe European Commission (EC) has granted marketing authorisation to biopharmaceutical company Gilead Sciences, for two doses of Descovy (emtricitabine and tenofovir alafenamide 200/10mg and 200/25mg;2016/4/28
-
Ireland’s Allergan acquires US manufacturer Topokine TherapeuticsIrish pharmaceutical giant Allergan has acquired Topokine Therapeutics, a US-based manufacturer of topical medicines for fat reduction, in a deal valued at $85m. The deal value includes Topokine's de2016/4/28
-
Lannett and YiChang to develop generic insulin product for US marketGeneric pharmaceutical products developer and distributor Lannett Company has planned to develop a generic insulin pharmaceutical product for the US market. The product is now at its late stage devel2016/4/27
-
Merck's Keytruda gets FDA breakthrough therapy designation for cHLMerck, commonly known as MSD, has obtained breakthrough therapy designation from the US Food and Drug Administration (FDA) for its Keytruda (pembrolizumab) to treat patients with relapsed or refractor2016/4/27